newsfilter
← Latest News
GlobeNewswire·

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Completed enrollment in Phase 2 BESTOW trial assessing tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Presented updated data on 13